Kuehn Law Investigates CG Oncology Officers and Directors
Kuehn Law, PLLC is investigating whether certain officers and directors of CG Oncology, Inc. (NASDAQ: CGON) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing.
Kuehn Law, PLLC, a shareholder litigation law firm, has initiated an investigation into potential breaches of fiduciary duty by officers and directors of CG Oncology, Inc. (NASDAQ: CGON). The inquiry specifically focuses on allegations of self-dealing.
Shareholders who may have been harmed by these actions could be entitled to damages and may help bring about corporate governance reforms. The firm emphasizes that shareholder participation is crucial for market integrity.
CG Oncology shareholders are urged to contact Justin Kuehn, Esq., at Kuehn Law via email at justin@kuehn.law or by phone at (833) 672-0814. The firm offers free consultations and covers all case costs, with no obligation to the investor. The firm notes that there may be a limited time for shareholders to assert their rights.